🇨🇦 nab-paclitaxel, lobaplatin, and S-1 in Canada

nab-paclitaxel, lobaplatin, and S-1 (nab-paclitaxel, lobaplatin, and S-1) regulatory status in Canada.

Marketing authorisation

nab-paclitaxel, lobaplatin, and S-1 in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is nab-paclitaxel, lobaplatin, and S-1 approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for nab-paclitaxel, lobaplatin, and S-1 in Canada?

Yang Jianjun, PhD is the originator. The local marketing authorisation holder may differ — check the official source linked above.